Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study.

We aimed to assess the long-term safety and effectiveness of ocrelizumab in a cohort of patients with multiple sclerosis (MS) at high risk of progressive multifocal leukoencephalopathy (PML), previously treated with natalizumab in extending interval dosing (EID), who switched to ocrelizumab and to compare them with patients who continued EID-natalizumab. Thirty MS patients previously treated with natalizumab in EID (every 8 weeks) were included in this observational retrospective cohort study. Among them, 17 patients were switched to ocrelizumab and 13 continued with EID-natalizumab. Except for the John Cunningham virus (JCV) index, no significant differences were detected between both groups. Main outcome measures included: annualized relapse rate (ARR), radiological activity, disability progression, and the NEDA-3 index. Patients were followed for 96 weeks. The median washout period in ocrelizumab-switchers was 6 weeks. Among them, AAR and radiological activity during follow-up were 0.03, without significant differences in comparison with the previous period on natalizumab-EID. The comparison between ocrelizumab-switchers and patients continuing on EID-natalizumab showed no significant differences in AAR, radiological activity, or disability progression. However, the proportion of patients maintaining a NEDA-3 status in week 96 was slightly superior among ocrelizumab-switchers (94 vs 69%). No serious adverse events were observed in any group. In conclusion, switching from EID-natalizumab to ocrelizumab can be considered as a therapeutic option, particularly in patients with MS at high risk of PML, to mitigate the risks of both PML and disease reactivation.

Influence of different types of compression garments on exercise-induced muscle damage markers after a soccer match.

There is not enough evidence of positive effects of compression therapy on the recovery of soccer players after matches. Therefore, the objective was to evaluate the influence of different types of compression garments in reducing exercise-induced muscle damage (EIMD) during recovery after a friendly soccer match. Eighteen semi-professional soccer players (24 ± 4.07 years, 177 ± 5 cm; 71.8 ± 6.28 kg and 22.73 ± 1.81 BMI) participated in this study. A two-stage crossover design was chosen. Participants acted as controls in one match and were assigned to an experimental group (compression stockings group, full-leg compression group, shorts group) in the other match. Participants in experimental groups played the match wearing the assigned compression garments, which were also worn in the 3 days post-match, for 7 h each day. Results showed a positive, but not significant, effect of compression garments on attenuating EIMD biomarkers response, and inflammatory and perceptual responses suggest that compression may improve physiological and psychological recovery.

Physiological and physical responses to wearing compression garments during soccer matches and recovery.

BACKGROUND: There is not enough information on the effects of compression therapy in soccer players during recovery after matches. The objective of this study was to examine the effect of wearing compression garments during soccer matches and during recovery period on physical responses. METHODS: Eighteen semi-professional soccer players participated in this study. A two-stage crossover design was chosen. Participants acted as controls in one match and were assigned to an experimental group (compression stockings group, full-leg compression group, shorts group) in the other match. Participants in experimental groups played the match wearing assigned compression garments and were worn in the 3 days post-match, for 7 hours/day. Blood lactate concentration, arterial oxygen saturation of hemoglobin, perceived exertion, perceived recovery, anaerobic power (vertical jump, sprint, change of direction) and aerobic capacity (Yo-Yo Intermittent Recovery level 2) were measured. Internal and external loads were measured during both matches. RESULTS: Using compression garments may slightly increase lactate during and after soccer matches and only full-leg garments can moderately attenuate the reduction of arterial oxygen saturation of hemoglobin. Wearing compression garments can be useful between 24-48 hours post-exercise to promote psychological recovery, especially with full-leg garments and compression shorts. Decreases in anaerobic power can be attenuated but not significantly, mainly with full-leg compression garments or compression shorts. Compression garments could also have positive effect on aerobic capacity, but we cannot exclude a placebo effect. CONCLUSIONS: Compression garments could be moderately beneficial, but effects are not significant.